<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN" "http://www.w3.org/TR/REC-html40/loose.dtd"> <html><body> <h1 id="innovation-investments">Innovation Investments</h1> <h2 id="moonshots">Moonshots</h2> <ol> <li>AquaBounty Technologies Inc. (AQB) <ul> <li>Specialises in land-based seafood farming</li> <li>Produce and farm genetically engineered salmon spawns</li> </ul> </li> <li>Amyris Inc. (AMRS) <ul> <li>Leader in SynBio (synthetic biology)</li> <li>Currently focused on scaling up production of sustainable ingredients for clean health and beauty, flavours and fragrances</li> </ul> </li> <li>Gevo Inc. (GEVO) <ul> <li>Specialises in renewable alternatives to petroleum-based products</li> <li>Currently building a refinery that should meet their SAF (Sustainable Aviation Fuel) delivery agreements with major airline carriers world-wide.</li> </ul> </li> <li>Genmab (GMAB) <ul> <li>A very successful biotech company</li> <li>Specialises in cancer therapeutics</li> </ul> </li> <li>Bionano Genomics Inc. (BNGO) <ul> <li>OGM (Optical Genome Mapping) device manufacturer</li> <li>Specialises in low-cost, high-precision genome structural variation detection devices.</li> <li>Add an “I” to the ticker symbol to guess why I have my fingers crossed on this one</li> </ul> </li> <li>Pacific Biosciences of California Inc. (PACB) <ul> <li>Manufactures devices for long-read and short-read sequencing</li> <li>Competes with Bionano Genomics (BNGO) in the genome analysis space</li> </ul> </li> <li>Asensus Surgical Ltd. (ASXC) <ul> <li>Develops and manufactures minimally invasive surgical robots.</li> <li>A knee-jerk reaction to missing out on Intuitive Surgical (ISRG) 7 years ago</li> </ul> </li> <li>QuantumScape Corp. (QS) <ul> <li>Currently developing the most bleeding edge solid-state battery</li> </ul> </li> <li>NU Holdings Ltd. (NU) <ul> <li>Latin America’s largest fintech and neobank</li> </ul> </li> <li>StoneCo Ltd. (STNE) <ul> <li>Similar to Nu Holdings but caters for merchants and SMB (Small and Midsize Businesses).</li> </ul> </li> <li>Kopin Corp. (KOPN) <ul> <li>Develops and manufactures wearable technologies</li> <li>Their AR &amp; VR wearables have broad application across military, enterprise and industrial segments.</li> <li>Quite small and potentially an acquisition target.</li> </ul> </li> <li>Desktop Metal Inc. (DM) <ul> <li>Manufactures 3D-printers and provides additive manufacturing solutions across a very broad range of industries.</li> <li>Challenges in automation and mass production of 3D-printed components.</li> <li>Probably still struggling to streamline processes across acquired businesses.</li> </ul> </li> <li>Markforged Holding Corp. (MKFG) <ul> <li>Same as Desktop Metal (DM) but has advanced software solutions for automated and remote management of 3D-printing hardware.</li> </ul> </li> <li>CRISPR Therapeutics AG (CRSP), Intellia Therapeutics (NTLA), Editas Medicine (EDIT) <ul> <li>Advanced genome editing companies</li> <li>Thumb twiddling, while waiting for impactful progress and reasonable entry points</li> </ul> </li> <li>Schrödinger (SDGR), Recursion Pharmaceuticals (RXRX), AbCellera Biologics (ABCL) <ul> <li>Providers of simulation and computing software platforms for accelerated drug discovery.</li> </ul> </li> <li>NIO Inc. (NIO) <ul> <li>Manufacturer of affordable luxury EVs with autonomous driving experience.</li> </ul> </li> </ol> <h2 id="enablers">Enablers</h2> <ol> <li>Vale (VALE), Freeport-McMoRan Inc. (FCX), Rio Tinto PLC (RIO), BHP Group Ltd. (BHP) <ul> <li>Mineral resources for the electrification revolution and EV industry.</li> </ul> </li> <li>Maravai LifeSciences Holdings (MRVI) <ul> <li>Provides products/reagents for R&amp;D of various therapies, vaccines and diagnostic solutions</li> <li>Biggest supplier of mRNA vaccine reagents to Pfizer, BioNTech and Moderna.</li> </ul> </li> <li>Pyrogenesis Canada Inc. (PYR) <ul> <li>Provides green industrial waste management solutions and industrial process optimisations.</li> <li>The CEO’s unwillingness to disclose names of newly signed on customers is a red flag and cause for worry.</li> </ul> </li> </ol> <h2 id="risks">Risks</h2> <h2 id="opportunities">Opportunities</h2> </body></html>